GVEZX
Price
$18.95
Change
+$0.21 (+1.12%)
Updated
Jun 6 closing price
Net Assets
976.21M
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

GVEZX vs VIVAX

Header iconGVEZX vs VIVAX Comparison
Open Charts GVEZX vs VIVAXBanner chart's image
GuideStone Funds Value Equity Investor
Price$18.95
Change+$0.21 (+1.12%)
VolumeN/A
Net Assets976.21M
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
GVEZX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVEZX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVEZX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. GVEZX (976M). VIVAX pays higher dividends than GVEZX: VIVAX (2.16) vs GVEZX (1.18). GVEZX was incepted earlier than VIVAX: GVEZX (24 years) vs VIVAX (33 years). GVEZX (0.90) is less costly to investors than VIVAX (0.17). GVEZX is a more actively managed with annual turnover of: 62.00 vs. VIVAX (9.00). GVEZX has a lower initial minimum investment than VIVAX: GVEZX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. GVEZX (-1.06). VIVAX return over 5 years is better than : 58.70 vs. GVEZX (14.58).
GVEZXVIVAXGVEZX / VIVAX
Total Expense Ratio0.900.17529%
Annual Report Gross Expense Ratio0.900.17529%
Fund Existence24 years33 years-
Gain YTD-0.0531.238-4%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets976M189B1%
Annual Yield % from dividends1.182.1655%
Returns for 1 year-1.066.81-16%
Returns for 3 years-6.2218.51-34%
Returns for 5 years14.5858.7025%
Returns for 10 years-2.77102.90-3%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc